Medical Device News Magazine

Chung-Ang University Researchers Develop Novel DNA Biosensor for Early Diagnosis of Cervical Cancer

Chung-Ang University Researchers Develop Novel DNA Biosensor for Early Diagnosis of Cervical Cancer

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Molybdenum disulfide (MoS2) has recently garnered attention among materials science researchers owing to its ability to form two-dimensional nanosheets like graphene. The nanosheets are created by the stacking of S–Mo–S layers interacting via Van der Waals interactions. Additionally, the unique structural, optical, thermal, and electrochemical properties of MoS2 have opened up multiple research avenues across several fields, including the development of biomolecule sensing and chemical detection platforms, optoelectronics, supercapacitors, and batteries.

Traditionally, carbon nanostructures have been employed as an immobilization platform for DNA. In order to substitute carbon with MoS2 as an effective electrochemical DNA sensor, the electrical conductivity of MoS2 needs to be improved considerably. Against this backdrop, Associate Professor Eunah Kang and Mr. Youngjun Kim from the School of Chemical Engineering and Material Science at Chung-Ang University, Korea have recently come up with an elegant solution. The duo has developed an electrochemical DNA biosensor using a graphitic nano-onion/molybdenum disulfide (MoS2) nanosheet composite, which effectively detects human papillomavirus (HPV)-16 and HPV-18, and can serve as an early diagnosis of cervical cancer.

“Nano-onions possess graphitic sp2 structures and are derived from crystalline sp3 nanodiamonds via thermal annealing or laser irradiation,” explains Dr. Kang. Their breakthrough was published in Volume 21 of the Journal of Nanobiotechnology on 10 June 2023.

The researcher duo prepared the novel electrode surface for probing DNA chemisorption by enabling chemical conjugation between two functional groups: acyl bonds on the surfaces of functionalized nano-onions and amine groups present on the modified MoS2 nanosheets. Cyclic voltammetry experiments revealed that a 1:1 composite electrode had an improved rectangular shape compared to that of an MoS2 nanosheet electrode. “This indicated the amorphous nature of the nano-onions with curved carbon layers that facilitated an enhancement in electronic conductivity compared to MoS2 nanosheet alone,” highlights Dr. Kang.

Additionally, the duo measured the sensitivity of their novel electrochemical DNA biosensor device towards HPV-16 and HPV-18 by employing differential pulse voltammetry (DPV) technique in the presence of methylene blue (MB) as a redox indicator. Dr. Kang elaborates: “The DPV current peak was lowered after probe DNA chemisorption and target DNA hybridization. Since the hybridized DNA was double-stranded, it induced less effective MB electrostatic intercalation, resulting in a lower oxidation peak.”

The duo found that, compared to the MoS2 nanosheet electrode, the nano-onion/MoS2 nanosheet composite electrode attained higher current peaks, indicating a greater change in the differential peak. This was attributed to an enhanced conductive electron transfer owing to the nano-onion.

Notably, the target DNAs produced from HPV-16 and HPV-18 Siha and Hela cancer cell lines were detected by the proposed sensor effectively and with high specificity. Consequently, MoS2 nanosheets with improved electrical conductivity facilitated by complexation with nano-onions provides a suitable platform for developing effective and efficient electrochemical biosensors for the early diagnosis of a wide variety of ailments, including cervical cancer.

Furthermore, combining nano-onions or nanodiamonds with different organic biomaterials can facilitate chemical functionality, electron transfer conductivity, light absorption, and more. These, in turn, can lead to innovative disease sensing, targeted drug delivery systems, and biomedical imaging and diagnostics.

Reference

Title of original paper: A graphitic nano-onion/molybdenum disulfide nanosheet composite as a platform for HPV-associated cancer-detecting DNA biosensors

Journal: Journal of Nanobiotechnology

DOI: https://doi.org/10.1186/s12951-023-01948-6

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”